Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Babka R., Colby C., El-Etr A., Pifarré R. Monitoring of intraoperative heparinization and blood loss following cardiopulmonary bypass surgery. J Thorac Cardiovasc Surg. 1977 May;73(5):780–782. [PubMed] [Google Scholar]
- Bull B. S., Huse W. M., Brauer F. S., Korpman R. A. Heparin therapy during extracorporeal circulation. II. The use of a dose-response curve to individualize heparin and protamine dosage. J Thorac Cardiovasc Surg. 1975 May;69(5):685–689. [PubMed] [Google Scholar]
- Bull B. S., Korpman R. A., Huse W. M., Briggs B. D. Heparin therapy during extracorporeal circulation. I. Problems inherent in existing heparin protocols. J Thorac Cardiovasc Surg. 1975 May;69(5):674–684. [PubMed] [Google Scholar]
- Esposito R. A., Culliford A. T., Colvin S. B., Thomas S. J., Lackner H., Spencer F. C. The role of the activated clotting time in heparin administration and neutralization for cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1983 Feb;85(2):174–185. [PubMed] [Google Scholar]
- Hattersley P. G. Activated coagulation time of whole blood. JAMA. 1966 May 2;196(5):436–440. [PubMed] [Google Scholar]
- Hill J. D., Dontigny L., De Leval M., Mielke C. H., Jr A simple method of heparin management during prolonged extracorporeal circulation. Ann Thorac Surg. 1974 Feb;17(2):129–134. doi: 10.1016/s0003-4975(10)65621-4. [DOI] [PubMed] [Google Scholar]
- Mattox K. L., Guinn G. A., Rubio P. A., Beall A. C., Jr Use of the activated coagulation time in intraoperative heparin reversal for cardiopulmonary operations. Ann Thorac Surg. 1975 Jun;19(6):634–638. doi: 10.1016/s0003-4975(10)63823-4. [DOI] [PubMed] [Google Scholar]
- Ogilby J. D., Kopelman H. A., Klein L. W., Agarwal J. B. Adequate heparinization during PTCA: assessment using activated clotting times. Cathet Cardiovasc Diagn. 1989 Dec;18(4):206–209. doi: 10.1002/ccd.1810180403. [DOI] [PubMed] [Google Scholar]
- Rath B., Bennett D. H. Monitoring the effect of heparin by measurement of activated clotting time during and after percutaneous transluminal coronary angioplasty. Br Heart J. 1990 Jan;63(1):18–21. doi: 10.1136/hrt.63.1.18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schriever H. G., Epstein S. E., Mintz M. D. Statistical correlation and heparin sensitivity of activated partial thromboplastin time, whole blood coagulation time, and an automated coagulation time. Am J Clin Pathol. 1973 Sep;60(3):323–329. doi: 10.1093/ajcp/60.3.323. [DOI] [PubMed] [Google Scholar]